Back to Search
Start Over
Discovery of a cinnamyl piperidine derivative as new neddylation inhibitor for gastric cancer treatment.
- Source :
-
European Journal of Medicinal Chemistry . Dec2021, Vol. 226, pN.PAG-N.PAG. 1p. - Publication Year :
- 2021
-
Abstract
- Targeting neddylation pathway has been recognized as an attractive anticancer therapeutic strategy, thus discovering potent and selective neddylation inhibitors is highly desirable. Our work reported the discovery of novel cinnamyl piperidine compounds and their antitumor activity in vitro and in vivo. Among these compounds, compound 4g was identified as a novel neddylation inhibitor and decreased the neddylation levels of cullin 1, cullin 3 and cullin 5. Mechanistic studies demonstrated that compound 4g could inhibit the migration ability of gastric cancer cells and induce apoptosis partly mediated by the Nrf2-Keap1 pathway. Furthermore, in vivo anti-tumor studies showed that 4g effectively inhibited tumor growth without obvious toxicity. Collectively, the cinnamyl piperidine derivatives could serve as new lead compounds for developing highly effective neddylation inhibitors for gastric cancer therapy. [Display omitted] • Compound 4g was identified as a novel neddylation inhibitor. • Compound 4g exhibited potent antiproliferation activity against MGC-803 cells. • Compound 4g could inhibit migration and induce apoptosis of gastric cancer cells. • In vivo anti-tumor studies showed that 4g effectively inhibited tumor growth without obvious toxicity. [ABSTRACT FROM AUTHOR]
- Subjects :
- *STOMACH cancer
*PIPERIDINE
*CANCER treatment
*ANTINEOPLASTIC agents
*TUMOR growth
Subjects
Details
- Language :
- English
- ISSN :
- 02235234
- Volume :
- 226
- Database :
- Academic Search Index
- Journal :
- European Journal of Medicinal Chemistry
- Publication Type :
- Academic Journal
- Accession number :
- 153623078
- Full Text :
- https://doi.org/10.1016/j.ejmech.2021.113896